US 9446028
Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome
granted A61KA61K31/437A61K9/0019
Quick answer
US patent 9446028 (Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome) held by OVID THERAPEUTICS INC. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/437, A61K9/0019, A61K9/0053, A61K9/7023